Next Article in Journal
Analysis of Clinicopathological and Molecular Features of Microcystic, Elongated, and Fragmented Pattern Invasion in Endometrioid Endometrial Cancer
Previous Article in Journal
Impact of the Immune Landscape in Follicular Lymphoma: Insights into Histological Transformation in the Rituximab Era
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 16
Issue 20
10.3390/cancers16203554
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Cancers 2023, 15(23), 5597.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Becker et al. Identifying Predictive Biomarkers for Head and Neck Squamous Cell Carcinoma Response. Cancers 2023, 15, 5597

by
Anne-Sophie Becker
1,*,
Cornelius Kluge
1,
Carsten Schofeld
1,
Annette Helene Zimpfer
1,
Björn Schneider
1,
Daniel Strüder
2,
Caterina Redwanz
3,
Julika Ribbat-Idel
4,
Christian Idel
5 and
Claudia Maletzki
6
1
Institute of Pathology, Rostock University Medical Center, 18057 Rostock, Germany
2
Department of Otorhinolaryngology, Head and Neck Surgery “Otto Koerner”, Rostock University Medical Center, 18057 Rostock, Germany
3
Department of Internal Medicine B, Cardiology, University Medicine Greifswald, 17475 Greifswald, Germany
4
Institute of Pathology, University of Luebeck, University Hospital Schleswig-Holstein, Campus Luebeck, 23538 Luebeck, Germany
5
Department of Oto-Rhino-Laryngology & Head and Neck Surgery, University of Lubeck, University Hospital Schleswig-Holstein, Campus Luebeck, 23538 Luebeck, Germany
6
Department of Internal Medicine, Medical Clinic III—Hematology, Oncology, Palliative Medicine, Rostock University Medical Center, 18057 Rostock, Germany
*
Author to whom correspondence should be addressed.
Cancers 2024, 16(20), 3554; https://doi.org/10.3390/cancers16203554
Submission received: 10 September 2024 / Accepted: 11 October 2024 / Published: 21 October 2024
Browse Figure
Versions Notes

Error in Figure

In the original publication [1], there was a mistake in Figure 3A, as published. The included legend of the survival curve on the right had a wrongly named second-line caption. The correct labeling of the subgroup (dark red line) is “FOXP3 high/CMTM6 low” instead of “FOXP3 low/CMTM6 low” (which is the caption for the royal blue line).
The corrected Figure 3A appears below. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Becker, A.-S.; Kluge, C.; Schofeld, C.; Zimpfer, A.H.; Schneider, B.; Strüder, D.; Redwanz, C.; Ribbat-Idel, J.; Idel, C.; Maletzki, C. Identifying Predictive Biomarkers for Head and Neck Squamous Cell Carcinoma Response. Cancers 2023, 15, 5597. [Google Scholar] [CrossRef] [PubMed]
Cancers 16 03554 g003
Figure 3. Kaplan–Meier survival curves of HNSCC patients from the discovery cohort. For biomarker-driven and treatment-related prognosis, analysis was performed on n = 177 patients receiving first- or second-line treatment. Treatment regimens included chemotherapy, radiotherapy (RT), radio-chemotherapy (RCT), or ICI (immune checkpoint inhibition). (A) Overall survival (OS) of patients according to FOXP3 and combined FOXP3/CMTM6 status. (B) Treatment-related OS stratified according to the specific regimen and FOXP3/CMTM6 status. Cisplatin-based chemotherapy, RT, RCT, or ICI. Log-rank analysis was performed to study any differences between the individual regimens. n.s.—not significant.
Figure 3. Kaplan–Meier survival curves of HNSCC patients from the discovery cohort. For biomarker-driven and treatment-related prognosis, analysis was performed on n = 177 patients receiving first- or second-line treatment. Treatment regimens included chemotherapy, radiotherapy (RT), radio-chemotherapy (RCT), or ICI (immune checkpoint inhibition). (A) Overall survival (OS) of patients according to FOXP3 and combined FOXP3/CMTM6 status. (B) Treatment-related OS stratified according to the specific regimen and FOXP3/CMTM6 status. Cisplatin-based chemotherapy, RT, RCT, or ICI. Log-rank analysis was performed to study any differences between the individual regimens. n.s.—not significant.
Cancers 16 03554 g003
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Becker, A.-S.; Kluge, C.; Schofeld, C.; Zimpfer, A.H.; Schneider, B.; Strüder, D.; Redwanz, C.; Ribbat-Idel, J.; Idel, C.; Maletzki, C. Correction: Becker et al. Identifying Predictive Biomarkers for Head and Neck Squamous Cell Carcinoma Response. Cancers 2023, 15, 5597. Cancers 2024, 16, 3554. https://doi.org/10.3390/cancers16203554

AMA Style

Becker A-S, Kluge C, Schofeld C, Zimpfer AH, Schneider B, Strüder D, Redwanz C, Ribbat-Idel J, Idel C, Maletzki C. Correction: Becker et al. Identifying Predictive Biomarkers for Head and Neck Squamous Cell Carcinoma Response. Cancers 2023, 15, 5597. Cancers. 2024; 16(20):3554. https://doi.org/10.3390/cancers16203554

Chicago/Turabian Style

Becker, Anne-Sophie, Cornelius Kluge, Carsten Schofeld, Annette Helene Zimpfer, Björn Schneider, Daniel Strüder, Caterina Redwanz, Julika Ribbat-Idel, Christian Idel, and Claudia Maletzki. 2024. "Correction: Becker et al. Identifying Predictive Biomarkers for Head and Neck Squamous Cell Carcinoma Response. Cancers 2023, 15, 5597" Cancers 16, no. 20: 3554. https://doi.org/10.3390/cancers16203554

APA Style

Becker, A. -S., Kluge, C., Schofeld, C., Zimpfer, A. H., Schneider, B., Strüder, D., Redwanz, C., Ribbat-Idel, J., Idel, C., & Maletzki, C. (2024). Correction: Becker et al. Identifying Predictive Biomarkers for Head and Neck Squamous Cell Carcinoma Response. Cancers 2023, 15, 5597. Cancers, 16(20), 3554. https://doi.org/10.3390/cancers16203554

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop